Similar to amphiregulin and TGF-α, EGF is reported to promote breast tumorigenesis through EGFR activation [31–33], and inhibition of EGF/EGFR signaling has been shown to exert anti-tumor effects for breast cancer [34, 35]. This evidence concerns the gene AREG and breast carcinoma.